These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 30777117

  • 1. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S, Yan P, Yao C, Yan X, Huo Y, Zhang J, Liu S, Feng Z, Shang H, Xie L.
    Trials; 2019 Feb 18; 20(1):136. PubMed ID: 30777117
    [Abstract] [Full Text] [Related]

  • 2. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial.
    Zhang H, Li J, Yu X, Li S, Wang H, Ruan H, Si Y, Xie Y, Wang M.
    Trials; 2019 Dec 16; 20(1):735. PubMed ID: 31842969
    [Abstract] [Full Text] [Related]

  • 3. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
    Zu Y, Li D, Lei X, Zhang H.
    Trials; 2019 Nov 27; 20(1):647. PubMed ID: 31775843
    [Abstract] [Full Text] [Related]

  • 4. Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial.
    Wang P, Song Y, Liu Z, Wang H, Zheng W, Liu S, Feng Z, Zhai J, Yao C, Ren M, Bai C, Shang H.
    Trials; 2016 Mar 17; 17(1):142. PubMed ID: 26983754
    [Abstract] [Full Text] [Related]

  • 5. High-intensity versus low-intensity noninvasive positive pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (HAPPEN): study protocol for a multicenter randomized controlled trial.
    Luo Z, Wu C, Li Q, Zhu J, Pang B, Shi Y, Ma Y, Cao Z, HAPPEN collaboration group.
    Trials; 2018 Nov 21; 19(1):645. PubMed ID: 30463622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
    Haifeng W, Jiansheng L, Suyun L, Xueqing Y, Hailong Z, Zhiwan W, Qiyi W, Pankui Z, Zhongchao W, Fenglei L, Haihong Y.
    Trials; 2012 Apr 20; 13():40. PubMed ID: 22520863
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial.
    Kong Q, Mo S, Wang W, Tang Z, Wei Y, Du Y, Liu B, Kong L, Lv Y, Dong J.
    Trials; 2020 Sep 03; 21(1):760. PubMed ID: 32883322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
    Sun Y, Chen X, Zhang L, Yuan WA, Chen Q, Zhang YB, Liu LJ, Zhang W, Sun M.
    Drug Des Devel Ther; 2022 Sep 03; 16():4251-4267. PubMed ID: 36540716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of traditional Chinese medicine on outcomes in patients with mild/moderate chronic obstructive pulmonary disease: study protocol for a randomized placebo-controlled trial.
    Wang M, Li J, Li S, Wang H, Yu X, Zhang H.
    Trials; 2012 Jul 16; 13():109. PubMed ID: 22799753
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C, Yuan Z, Pan X, Zhang J, Zhu J, Zhou F, Shan Z, Yuan Y, Ye R, Cheng J.
    Trials; 2020 Dec 23; 21(1):1029. PubMed ID: 33357239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
    Liu C, Hou Y, Wang X, Zhao Z, Liu Z, Zhai J, Mao J, Shang H.
    Trials; 2015 May 21; 16():222. PubMed ID: 25994188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.
    Li JS, Xie Y, Li SY, Yu XQ.
    Trials; 2014 May 01; 15():153. PubMed ID: 24885672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G.
    Trials; 2020 Jun 08; 21(1):495. PubMed ID: 32513299
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.